GZMK-expressing tissue-resident memory CD8+ T cells participate in human intestinal acute graft-versus-host disease
JCI Insight · 22.07.2026 · 11 (14)
DOI: 10.1172/jci.insight.199156 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, online erschienen am 22.07.2026. Verfasst von Yiming Sun und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Graft vs Host Disease, CD8-Positive T-Lymphocytes, Memory T Cells, Intestinal Diseases. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Science and Technology Planning Project of Guangdong Province, the National Major Scientific and Technological Projects, the Clinical Research Project of Nanfang Hospital, Southern Medical University.
Abstract (Originalsprache)
Intestinal acute graft-versus-host disease (aGVHD) is a common life-threatening complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Although tissue-resident memory T (TRM) cells are thought to play a pathophysiological role in animal models of aGVHD, little is known about the role of distinct subsets of TRM cells in human intestinal aGVHD. Herein, we combined multiplex immunohistochemical staining with single-cell RNA sequencing to elucidate the differentiation trajectory, lineage commitment, clonal expansion, and functional properties of distinct CD8 + TRM cell subsets in human intestinal aGVHD. We identified a predominant GZMK + CD8 + TRM subset, characterized by the GZMK and CD49A markers. Intestinal aGVHD was associated with infiltration of GZMK + CD8 + T cells with TRM features, which showed enhanced clonal expansion, IFN signaling pathway–associated proinflammatory pathway expression, and lineage bifurcation differentiation properties. High GZMK + CD8 + TRM subset infiltration was associated with greater human intestinal aGVHD severity and poor prognosis. Together, our studies highlight the importance of the GZMK + CD8 + TRM subset in human intestinal aGVHD, and interest for designing GZMK + CD8 + TRM cell–targeted therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Förderung
- the Science and Technology Planning Project of Guangdong Province
- the National Major Scientific and Technological Projects
- the Clinical Research Project of Nanfang Hospital, Southern Medical University
- the Science and Technology Project of Ganzhou City
- the National Natural Science Foundation of China
Zitieren
APA
Sun, Y., Xue, Y., Song, C., Liu, X., Shao, R., Fan, Z., Lin, R., Huang, F., Xu, N., Xuan, L., Dai, M., Sun, J., Liu, Q., & Jin, H. (2026). GZMK-expressing tissue-resident memory CD8+ T cells participate in human intestinal acute graft-versus-host disease. JCI Insight, 11(14). https://doi.org/10.1172/jci.insight.199156
Vancouver
Sun Y, Xue Y, Song C, Liu X, Shao R, Fan Z, et al. GZMK-expressing tissue-resident memory CD8+ T cells participate in human intestinal acute graft-versus-host disease. JCI Insight. 2026;11(14). doi:10.1172/jci.insight.199156
BibTeX
@article{Sun2026,
author = {Sun, Yiming and Xue, Yutong and Song, Chenyuyao and Liu, Xinyu and Shao, Ruoyang and Fan, Zhiping and Lin, Ren and Huang, Fen and Xu, Na and Xuan, Li and Dai, Min and Sun, Jing and Liu, Qifa and Jin, Hua},
title = {GZMK-expressing tissue-resident memory CD8+ T cells participate in human intestinal acute graft-versus-host disease},
journal = {JCI Insight},
year = {2026},
volume = {11},
number = {14},
doi = {10.1172/jci.insight.199156}
}
EUVIMED